General Information of Drug Off-Target (DOT) (ID: OTL29A51)

DOT Name Tetratricopeptide repeat protein 9A (TTC9)
Synonyms TPR repeat protein 9A
Gene Name TTC9
Related Disease
Opioid dependence ( )
UniProt ID
TTC9A_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF07719
Sequence
MERKGSAAGAKGNPSPPAAGEGQRPPPPLCVPGGGGGAPARGQVGAAAEPAELIRRAHEF
KSQGAQCYKDKKFREAIGKYHRALLELKGLLPPPGERERDSRPASPAGALKPGRLSEEQS
KTVEAIEIDCYNSLAACLLQAELVNYERVKEYCLKVLKKEGENFKALYRSGVAFYHLGDY
DKALYYLKEARTQQPTDTNVIRYIQLTEMKLSRCSQREKEAM

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Opioid dependence DIS6WEHK Strong Biomarker [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Tetratricopeptide repeat protein 9A (TTC9). [2]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Tetratricopeptide repeat protein 9A (TTC9). [3]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Tetratricopeptide repeat protein 9A (TTC9). [4]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Tetratricopeptide repeat protein 9A (TTC9). [5]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Tetratricopeptide repeat protein 9A (TTC9). [6]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Tetratricopeptide repeat protein 9A (TTC9). [7]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of Tetratricopeptide repeat protein 9A (TTC9). [8]
Zoledronate DMIXC7G Approved Zoledronate increases the expression of Tetratricopeptide repeat protein 9A (TTC9). [9]
Testosterone enanthate DMB6871 Approved Testosterone enanthate affects the expression of Tetratricopeptide repeat protein 9A (TTC9). [10]
Malathion DMXZ84M Approved Malathion decreases the expression of Tetratricopeptide repeat protein 9A (TTC9). [11]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Tetratricopeptide repeat protein 9A (TTC9). [13]
Coumestrol DM40TBU Investigative Coumestrol decreases the expression of Tetratricopeptide repeat protein 9A (TTC9). [14]
KOJIC ACID DMP84CS Investigative KOJIC ACID increases the expression of Tetratricopeptide repeat protein 9A (TTC9). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Tetratricopeptide repeat protein 9A (TTC9). [12]
------------------------------------------------------------------------------------

References

1 Substance dependence low-density whole genome association study in two distinct American populations. Hum Genet. 2008 Jun;123(5):495-506. doi: 10.1007/s00439-008-0501-0. Epub 2008 Apr 26.
2 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
3 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
4 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
5 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
6 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
7 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
8 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
9 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
10 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
11 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
12 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
13 Bisphenolic compounds alter gene expression in MCF-7 cells through interaction with estrogen receptor . Toxicol Appl Pharmacol. 2020 Jul 15;399:115030. doi: 10.1016/j.taap.2020.115030. Epub 2020 May 6.
14 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
15 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.